The IGF and their binding proteins play significant roles, and experimental reduction in IGF-I is instrumental in reducing intestinal smooth muscle hyperplasia and excess collagen production in TNBS-induced colitis in mice [57]. This evidence concerns the gene IGF1 and colitis.